AMBER CLARK: Open Payments
NPI 1992358485 · POOLER, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$715 in 37 payments from 9 companies in 2025. Trend: 2023 $1,064 · 2024 $826 · 2025 $715
Food & beverage: $715
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $185 |
| Novo Nordisk Inc | 10 | $162 |
| GlaxoSmithKline, LLC. | 11 | $157 |
| PFIZER INC. | 3 | $54 |
| Exact Sciences Corporation | 3 | $48 |
| ABBVIE INC. | 2 | $46 |
| Lilly USA, LLC | 2 | $34 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Dexcom, Inc. | 1 | $14 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, Ozempic, Rybelsus, Cologuard Collection Kit, UBRELVY, Wegovy, PREVNAR 20.
Industry payments across GA — which companies pay providers there.
